Phase I Clinical Trial Assessing Temozolomide and Tamoxifen With Concomitant Radiotherapy for Treatment of High-Grade Glioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I Clinical Trial Assessing Temozolomide and Tamoxifen With Concomitant Radiotherapy for Treatment of High-Grade Glioma

Published:2012-02 Issue:2 Volume:82 Page:739-742
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Patel Shilpen,DiBiase Steven,Meisenberg Barry,Flannery Todd,Patel Ashish,Dhople Anil,Cheston Sally,Amin Pradip

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference21 articles.

1. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials;Curran;J Natl Cancer Inst,1993

2. Brain tumors;DeAngelis;N Engl J Med,2001

3. Factors influencing survival in high-grade gliomas;Buckner;Semin Oncol,2003

4. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-Year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009

5. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: A cooperative clinical trial;Walker;J Neurosurg,1978

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Determinants for Photodynamic Therapy Resistance and Improved Photosensitizer Delivery in Glioma;International Journal of Molecular Sciences;2024-08-09

2. A novel disulfide death-related genes prognostic signature identifies the role of IPO4 in glioma progression;Cancer Cell International;2024-05-11

3. A Review of Approaches to Potentiate the Activity of Temozolomide against Glioblastoma to Overcome Resistance;International Journal of Molecular Sciences;2024-03-12

4. Assessing the Value of Disulfide Death-Associated Genes in the Prognosis and Treatment of Glioma;2023-11-09

5. CDS-DB, an omnibus for patient-derived gene expression signatures induced by cancer treatment;Nucleic Acids Research;2023-10-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3